New heart catheter aims to zap dangerous rhythms safely

NCT ID NCT05543798

Recruiting now Disease control Sponsor: Imricor Medical Systems Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new catheter (Vision-MR 2.0) to treat ventricular tachycardia, a fast, dangerous heart rhythm, in people with ischemic heart disease. About 64 adults will undergo a procedure to burn small areas of heart tissue causing the abnormal rhythm. The goal is to stop the arrhythmia without serious side effects, but ongoing medication or future episodes may still occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTRICULAR TACHYCARDIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VENTRICULAR TACHYCARDIA

Contacts and locations

Locations

Amsterdam UMC
RECRUITING

Amsterdam, Netherlands
HagaZiekenhuis
NOT_YET_RECRUITING

The Hague, 2545 AA, Netherlands
Herzzentrum Leipzig
NOT_YET_RECRUITING

Leipzig, Saxony, 04289, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.